Xencor Inc
For the period ended Mar 31, 2025. Filed May 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 7, 2025
XNCR$39.39+2.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
(in thousands)
| Three Months EndedMarch 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from operating activities | ||
| Net loss | $(48,632) | $(74,116) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 2,693 | 3,035 |
| Accretion of discount on marketable debt securities | (2,126) | (6,911) |
| Stock-based compensation | 12,213 | 11,421 |
| Gain on sale of marketable debt securities | — | (3) |
| Change in fair value of equity securities | (941) | (2,325) |
| Asset impairment charges | 4,865 | 20,650 |
| Non-cash royalty revenue | (18,232) | (15,468) |
| Non-cash interest expense on liability related to the sale of future royalties | 8,664 | 9,665 |
| Loss on disposal of assets | — | 6 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | 23,405 | 2,976 |
| Prepaid expenses and other assets | 5,057 | 1,974 |
| Accounts payable | (568) | 2,097 |
| Accrued expenses | (3,154) | (10,073) |
| Operating lease, net | 168 | 213 |
| Others | 368 | — |
| Net cash used in operating activities | (16,220) | (56,859) |
| Cash flows from investing activities | ||
| Purchase of marketable securities | (103,873) | (136,532) |
| Purchase of patents | — | (929) |
| Purchase of property and equipment | (1,444) | (132) |
| Proceeds from maturities of marketable securities | 118,985 | 159,942 |
| Proceeds from sale of marketable securities | — | 9,969 |
| Net cash provided by investing activities | 13,668 | 32,318 |
| Cash flows from financing activities | ||
| Proceeds from the exercises of stock options | 2,974 | 1,787 |
| Cash paid to acquire noncontrolling interest | (1,725) | — |
| Net cash provided by financing activities | 1,249 | 1,787 |
| Net decrease in cash, cash equivalents, and restricted cash | (1,303) | (22,754) |
| Cash, cash equivalents, and restricted cash, beginning of period | 41,262 | 54,170 |
| Cash, cash equivalents, and restricted cash, end of period | $39,959 | $31,416 |
| Supplemental disclosure of cash flow information | ||
| Interest paid | $1 | $11 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.